Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3126-3130

  Schutte, Mieke ^a   Hruban, Ralph H ^a   Geradts, Joseph ^b   Maynard, Rob ^b   Hilgers, Werner ^a   Rabindran, Sridhar K ^c   Moskaluk, Christopher A ^a   Hahn, Stephan A ^d   Schwarte Waldhoff, Irmgard ^d   Schmiegel, Wolff ^d   Baylin, Stephen B ^a   Kern, Scott E ^a   Herman, James G ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

^d RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SILENT GENE;

CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 13; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROZYGOTE; HUMANS; MUTATION; PANCREATIC NEOPLASMS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 16944367477     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
2. Hall, M., and Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res., 68: 67-108, 1996.
3. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Ke, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-31, 1994.
4. Rozenblum, E., Schutte, M., Goggins, M., Hahn, S. A., Panzer, S., Zuhurak, M., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., and Kern, S. E. Tumor suppressive pathways in pancreatic carcinoma. Cancer Res., 57: 1731-1734, 1997.
5. Seymour, A. B., Hruban, R. H., Redston, M. S., Caldas, C., Powell, S. M., Kinzler, K. W., Yeo, C. H., and Kern, S. E. Allelotype of pancreatic adenocarcinoma. Cancer Res., 54: 2761-2764, 1994.
6. Hahn, S. A., Seymour, A. B., Hoque, A. T. M. S., Schutte, M., da Costa, L. T., Redston, M. S., Caldas, C., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res. 55: 4670-4675, 1995.
7. Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
8. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Washington DC), 269; 1281-1284, 1995.
9. INK4a binding domain of CDK4 in familial melanoma. Nat. Genet., 12: 97-99, 1996.
10. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Molnar Nadasky, G., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res. 56: 2527-2530, 1996.
11. Rabindran, S. K., Wisniewski, J., Li, L., Li, G. C, and Wu, C. Interaction between heat shock factor and hsp70 is insufficient to suppress induction of DNA binding activity in vivo. Mol. Cell Biol., 14: 6552-6560, 1994.
12. Geradts, J., Hu, S-X., Lincoln, C. E., Benedict, W. F., and Xu, H-J. Aberrant RB gene expression in routinely processed archival tumor tissues determined by three different anti-RB antibodies. Int. J. Cancer, 58: 161-167, 1994.
13. Herman. J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J-P. J., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
14. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
15. Bartkova, J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A. F., Zeuthen, J., and Bartek, J. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res., 56: 5475-5483, 1996.
16. Naumann, M., Savitskaia, N., Eilert, C., Schramm, A., Kalthoff, H., and Schmiegel, W. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Gastroenterology, 110: 1215-1224, 1996.
17. Jiang, W., Zhang, Y-J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S-H., Harris, C. C., Monlesano, R., and Weinstein, I. B. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA, 90: 9026-9030, 1993.
18. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene, 9: 3375-3378, 1994.
19. He, J., Allen, J. R., Collins, V. P., Allalunis-Turner, M. J., Godbout, R., Day, R. S., III, and James, C. D. CDK4 amplification is an alternative mechanism of p16 gene homozygous deletion in glioma cell lines. Cancer Res., 54: 5804-5807, 1994.
20. Schmidt, E. E., Ichimura, K., Reifenberger, G., and Collins, V. P. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54: 6321-6324, 1994.
21. INK4a expression in resected non-small lung tumors. Cancer Res., 50: 3415-3420, 1996.
22. INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res., 56: 5557-5562, 1996.
23. INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene, 13: 1065-1072, 1996.
24. Barton, C. M., McKie, A. B., Hogg, A., Bia, B., Elia, G., Phillips, S. M. A., Ding, S-F., and Lemoine, N. R. Abnormalities of the RB1 and DCC tumor suppressor genes: uncommon in human pancreatic adenocarcinoma. Mol. Carcinog., 13: 61-69, 1995.
25. Huang, L., Lang, D., Geradts, J., Obara, T., Klein-Szanto, A. J. P., Lynch, H. T., and Ruggeri, B. A. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines. Mol. Carcinog., 15: 85-95, 1996.
26. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J-P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., in press, 1997.